Randomized, Double-blind, Placebo-controlled Trial, to Evaluate the Safety and Immunogenicity of Orally Administered, Killed, Bivalent Whole-cell, Cholera Vaccine, ShanChol in Bangladeshi Adults and Children.

Trial Profile

Randomized, Double-blind, Placebo-controlled Trial, to Evaluate the Safety and Immunogenicity of Orally Administered, Killed, Bivalent Whole-cell, Cholera Vaccine, ShanChol in Bangladeshi Adults and Children.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2014

At a glance

  • Drugs Cholera vaccine inactivated (Primary)
  • Indications Cholera
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Dec 2012 Planned End Date changed from 1 Nov 2010 to 1 Feb 2015 as reported by ClinicalTrials.gov.
    • 03 Dec 2012 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top